| 000 | 01271 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250512201032.0 | ||
| 264 | 0 | _c19810915 | |
| 008 | 198109s 0 0 eng d | ||
| 022 | _a0160-2446 | ||
| 024 | 7 |
_a10.1097/00005344-198103000-00007 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAnavekar, S N | |
| 245 | 0 | 0 |
_aVerapamil in the treatment of hypertension. _h[electronic resource] |
| 260 |
_bJournal of cardiovascular pharmacology _c |
||
| 300 |
_a287-92 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPindolol _xtherapeutic use |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 |
_aVerapamil _xadverse effects |
| 700 | 1 | _aChristophidis, N | |
| 700 | 1 | _aLouis, W J | |
| 700 | 1 | _aDoyle, A E | |
| 773 | 0 |
_tJournal of cardiovascular pharmacology _gvol. 3 _gno. 2 _gp. 287-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00005344-198103000-00007 _zAvailable from publisher's website |
| 999 |
_c6166851 _d6166851 |
||